Nymox Pharmaceutical
NYMX
#9973
Rank
โ‚ฌ16.81 M
Marketcap
Country
0,18ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -โ‚ฌ2.11 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -โ‚ฌ6.02 Million, an increase over its 2021 earnings that were of -โ‚ฌ11.5 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ2.11 Million-64.96%
2022 -โ‚ฌ6.02 Million-47.71%
2021 -โ‚ฌ11.5 Million6.61%
2020 -โ‚ฌ10.79 Million-10.91%
2019 -โ‚ฌ12.11 Million24.24%
2018 -โ‚ฌ9.75 Million-20.03%
2017 -โ‚ฌ12.19 Million2.71%
2016 -โ‚ฌ11.86 Million-63.86%
2015 -โ‚ฌ32.83 Million674.44%
2014 -โ‚ฌ4.24 Million-6.11%
2013 -โ‚ฌ4.52 Million-35.66%
2012 -โ‚ฌ7.02 Million-20.76%
2011 -โ‚ฌ8.86 Million38.33%
2010 -โ‚ฌ6.41 Million35.59%
2009 -โ‚ฌ4.73 Million11.8%
2008 -โ‚ฌ4.23 Million-12.94%
2007 -โ‚ฌ4.85 Million8.85%
2006 -โ‚ฌ4.46 Million36.5%
2005 -โ‚ฌ3.27 Million-4.4%
2004 -โ‚ฌ3.42 Million-14.58%
2003 -โ‚ฌ4 Million
2001 -โ‚ฌ2.94 Million-20.54%
2000 -โ‚ฌ3.7 Million21.72%
1999 -โ‚ฌ3.04 Million-25.56%
1998 -โ‚ฌ4.08 Million101.3%
1997 -โ‚ฌ2.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ6.45 B-324,625.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.23 B-514,352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.08 B-54,472.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.67 B-586,883.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ16.06 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA